MedTrace Logo

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

NCT07454174 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-06

No results posted yet for this study

Summary

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DIETARY_SUPPLEMENT

Ren-Nu and KetoCitra

This is a structured, nutritionist monitored program supplemented with a nutritional food product, while monitoring metabolic parameters

Sponsors & Collaborators

  • Santa Barbara Nutrients

    collaborator UNKNOWN

  • Richard Fatica

    lead OTHER

Principal Investigators

  • Richard Fatica, MD · The Cleveland Clinic

  • Thomas Weimbs, PhD · Santa Barbara Nutrients

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-25
Primary Completion
2027-02-28
Completion
2028-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454174 on ClinicalTrials.gov